Why Is Air Lease (AL) Up 6.5% Since Last Earnings Report?
https://www.zacks.com/stock/news/2194326/why-is-air-lease-al-up-6-5-since-last-earnings-report?cid=CS-ZC-FT-realtime_blog-2194326
Dec 06, 2023 - Air Lease (AL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
0
SentinelOne (S) Q3 Earnings Beat Estimates, Revenues Up Y/Y
https://www.zacks.com/stock/news/2194283/sentinelone-s-q3-earnings-beat-estimates-revenues-up-y-y?cid=CS-ZC-FT-analyst_blog|earnings_article-2194283
Dec 06, 2023 - SentinelOne (S) third-quarter 2024 results reflect improved revenues driven by strong demand for its AI solutions.
0
United Parcel Service (UPS) Rises As Market Takes a Dip: Key Facts
https://www.zacks.com/stock/news/2194475/united-parcel-service-ups-rises-as-market-takes-a-dip-key-facts?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6v1-2194475
Dec 06, 2023 - In the most recent trading session, United Parcel Service (UPS) closed at $155.29, indicating a +0.73% shift from the previous trading day.
0
Air Transport Services (ATSG) Up 0.3% Since Last Earnings Report: Can It Continue?
https://www.zacks.com/stock/news/2194341/air-transport-services-atsg-up-0-3-since-last-earnings-report-can-it-continue?cid=CS-ZC-FT-realtime_blog-2194341
Dec 06, 2023 - Air Transport Services (ATSG) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
0
Coty (COTY) Up 15.2% Since Last Earnings Report: Can It Continue?
https://www.zacks.com/stock/news/2194937/coty-coty-up-15-2-since-last-earnings-report-can-it-continue?cid=CS-ZC-FT-realtime_blog-2194937
Dec 07, 2023 - Coty (COTY) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
0
Theravance Bio (TBPH) Up 2.5% Since Last Earnings Report: Can It Continue?
https://www.zacks.com/stock/news/2194974/theravance-bio-tbph-up-2-5-since-last-earnings-report-can-it-continue?cid=CS-ZC-FT-realtime_blog-2194974
Dec 07, 2023 - Theravance Bio (TBPH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
0
Jack Henry (JKHY) Up 10.3% Since Last Earnings Report: Can It Continue?
https://www.zacks.com/stock/news/2194965/jack-henry-jkhy-up-10-3-since-last-earnings-report-can-it-continue?cid=CS-ZC-FT-realtime_blog-2194965
Dec 07, 2023 - Jack Henry (JKHY) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
0
Nutanix (NTNX) Is Up 8.40% in One Week: What You Should Know
https://www.zacks.com/stock/news/2195040/nutanix-ntnx-is-up-8-40-in-one-week-what-you-should-know?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_10-2195040
Dec 07, 2023 - Does Nutanix (NTNX) have what it takes to be a top stock pick for momentum investors? Let's find out.
0
Journey Medical (DERM) Up on Update for Skin Disease Candidate
https://www.zacks.com/stock/news/2194715/journey-medical-derm-up-on-update-for-skin-disease-candidate?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2194715
Dec 07, 2023 - Journey Medical (DERM) plans to submit a new drug application (NDA) to the FDA for DFD-29 to treat rosacea in adults by 2023-end. Stock rises.
0
Pharvaris (PHVS) Stock Up 18% on HAE Drug Meeting Study Goal
https://www.zacks.com/stock/news/2195115/pharvaris-phvs-stock-up-18-on-hae-drug-meeting-study-goal?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2195115
Dec 07, 2023 - Data from a mid-stage study shows that treatment with Pharvaris' (PHVS) investigational HAE drug reduced the monthly attack rate by 84.5%.
0